The story appears on

Page A5

July 19, 2010

GET this page in PDF

Free for subscribers

View shopping cart

Related News

HomeMetroHealth and Science

Hope for transplant patients

MEDICAL experts in Shanghai are developing a novel therapy that will allow organ transplant patients to take less anti-rejection drugs, medical experts told an international forum in the city yesterday.

The therapy works by reorganizing regulatory T cells, which are responsible for most immune system reactions, thus a patient's immune system will be less likely to attack the transplanted organ.

Currently, patients require anti-rejection drugs to survive after receiving an organ transplant. The drugs are expensive, have strong side effects and need to be taken for a long time.

According to Dr Fan Hui-min from Shanghai East Hospital's department of cardiology, regulatory T cells have been receiving a great deal of attention in the international medical field. The cells are capable of inhibiting most types of immune responses by not only maintaining immunological self-tolerance but also by limiting responses to foreign objects to the body.


 

Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.

娌叕缃戝畨澶 31010602000204鍙

Email this to your friend